Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clinically Isolated Syndrome of Demyelination”

3 trials

Showing 3 of 3 results

Testing effectiveness (Phase 2)Looking for participantsNCT05418010
What this trial is testing

Natalizumab for the Treatment of People With Inflammatory Demyelination Suggestive of Multiple Sclerosis, or Definite Multiple Sclerosis, at First Presentation (AttackMS)

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome of Demyelination
Queen Mary University of London 40
Not applicableStudy completedNCT02504840
What this trial is testing

Natural History of Multiple Sclerosis and Its Mimickers

Who this might be right for
Neurologic DisordersHealthy VolunteersMultiple Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS) 104
Not applicableStudy completedNCT01112657
What this trial is testing

An Observational Study on the Progression of Clinically Isolated Syndrome to Multiple Sclerosis Over a 2-year Period

Who this might be right for
Multiple Sclerosis
Merck KGaA, Darmstadt, Germany 154

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation